Rifaximin labels and packages: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Rifaximin}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = XIFAXAN (RIFAXIMIN) TABLET [SALIX PHARMACEUTI...") |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Labels And Packages== | |||
===PACKAGE LABEL - PRINCIPAL DISPLAY=== | |||
PACKAGE LABEL – PRINCIPAL DISPLAY – XIFAXAN 200 mg Tablets, 30 Tablet Bottle | |||
NDC 65649-301-03 | |||
Xifaxan® | |||
(rifaxamin) tablets 200 mg | |||
Rx only | |||
30 tablets | |||
{| | |||
|- | |||
| [[File:|800px|thumb]] | |||
|- | |||
|} | |||
===PACKAGE LABEL - PRINCIPAL DISPLAY=== | |||
PACKAGE LABEL – PRINCIPAL DISPLAY – XIFAXAN 550 mg Tablets, 60 Tablets Bottle Label | |||
NDC 65649-303-02 | |||
Xifaxan® | |||
(rifaximin) 550 mg tablets | |||
60 Tablets Unit Dose | |||
Rx ONLY<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = XIFAXAN (RIFAXIMIN) TABLET [SALIX PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1 | publisher = | date = | accessdate = }}</ref> | |||
{| | |||
|- | |||
| [[File:|800px|thumb]] | |||
|- | |||
|} | |||
Latest revision as of 21:41, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels And Packages
PACKAGE LABEL - PRINCIPAL DISPLAY
PACKAGE LABEL – PRINCIPAL DISPLAY – XIFAXAN 200 mg Tablets, 30 Tablet Bottle
NDC 65649-301-03
Xifaxan® (rifaxamin) tablets 200 mg
Rx only
30 tablets
| [[File:|800px|thumb]] |
PACKAGE LABEL - PRINCIPAL DISPLAY
PACKAGE LABEL – PRINCIPAL DISPLAY – XIFAXAN 550 mg Tablets, 60 Tablets Bottle Label
NDC 65649-303-02
Xifaxan® (rifaximin) 550 mg tablets
60 Tablets Unit Dose
Rx ONLY[1]
| [[File:|800px|thumb]] |
References
Adapted from the FDA Package Insert.